Provexis (PXS) Competitors GBX 0.57 -0.05 (-8.64%) As of 02/14/2025 11:38 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitors PXS vs. NSH, ALK, SHIP, TORO, CLCO, ICON, PAA, GEL, MMP, and AALShould you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Norish (NSH), Alkemy Capital Investments (ALK), Tufton Oceanic Assets (SHIP), Chenavari Toro Income Fund (TORO), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), and Anglo American (AAL). These companies are all part of the "transportation" industry. Provexis vs. Norish Alkemy Capital Investments Tufton Oceanic Assets Chenavari Toro Income Fund CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Anglo American Provexis (LON:PXS) and Norish (LON:NSH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk. Do insiders and institutionals hold more shares of PXS or NSH? 7.9% of Provexis shares are owned by institutional investors. 21.6% of Provexis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor PXS or NSH? Provexis received 16 more outperform votes than Norish when rated by MarketBeat users. However, 68.18% of users gave Norish an outperform vote while only 64.21% of users gave Provexis an outperform vote. CompanyUnderperformOutperformProvexisOutperform Votes6164.21% Underperform Votes3435.79% NorishOutperform Votes4568.18% Underperform Votes2131.82% Which has stronger earnings & valuation, PXS or NSH? Norish has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than Norish, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProvexis£846.98K15.82-£619.15K-£0.03-21.65Norish£36.39M0.00N/A£6.10N/A Is PXS or NSH more profitable? Norish has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Norish's return on equity of 0.00% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets Provexis-73.10% -68.68% -56.14% Norish N/A N/A N/A Does the media refer more to PXS or NSH? In the previous week, Provexis' average media sentiment score of 0.00 equaled Norish'saverage media sentiment score. Company Overall Sentiment Provexis Neutral Norish Neutral SummaryNorish beats Provexis on 7 of the 10 factors compared between the two stocks. Get Provexis News Delivered to You Automatically Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXS vs. The Competition Export to ExcelMetricProvexisDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£13.40M£2.35B£5.85B£2.66BDividend Yield5.06%2.92%5.27%5.11%P/E Ratio-21.654.3126.20159.00Price / Sales15.82682.65468.67317,183.20Price / CashN/A10.2546.1428.02Price / Book66.577.427.275.28Net Income-£619,153.31£20.70B£3.19B£5.75B7 Day Performance1.06%2.10%2.82%0.12%1 Month Performance-9.37%2.33%4.59%1.27%1 Year Performance-12.15%110.06%22.54%147.17% Provexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXSProvexisN/AGBX 0.57-8.6%N/A-15.4%£13.40M£846,984.38-21.654NSHNorishN/AN/AN/AN/A£52.62M£36.39M28.691,251Gap UpALKAlkemy Capital InvestmentsN/AGBX 173.45+3.6%N/A+69.1%£15.28MN/A-754.1325,500High Trading VolumeSHIPTufton Oceanic AssetsN/AGBX 1.16-0.9%N/A+8.3%£3.38M£39.75M9.6650TOROChenavari Toro Income FundN/AGBX 0.58+0.7%N/A+22.9%£1.79MN/A-19.47N/AHigh Trading VolumeCLCOCloudCoCo GroupN/AGBX 0.15-0.6%N/A-84.1%£1.09M£27.31M-115.00125ICONIconic LabsN/AN/AN/AN/A£586,000.00£600,855.00-15.003News CoverageGap UpHigh Trading VolumePAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660AALAnglo American1.5315 of 5 starsGBX 2,350+0.3%GBX 2,715+15.5%+41.0%£28.44B£29.44B-2,259.62129,700High Trading Volume Related Companies and Tools Related Companies Norish Alternatives Alkemy Capital Investments Alternatives Tufton Oceanic Assets Alternatives Chenavari Toro Income Fund Alternatives CloudCoCo Group Alternatives Iconic Labs Alternatives 22532 (PAA.L) Alternatives Greka Engineering & Technology Alternatives Marwyn Management Partners Alternatives Anglo American Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:PXS) was last updated on 2/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
